Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs URA✓SelectedUSD · URAGSK vs URA performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs URA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+6.9%
URA return
-32.3%
Excess return
+39.2%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioURAExcessAlpha
1D-1.6%-2.5%+1.0%-1.6%
7D-4.7%-11.4%+6.7%-4.8%
30D-4.7%-18.5%+13.8%-4.9%
3M-8.8%-36.3%+27.5%-8.9%
6M-4.6%-39.3%+34.6%-4.8%
YTD+1.0%-32.9%+33.9%-1.6%
1Y+6.9%-33.5%+40.3%+4.1%
All+6.9%-32.3%+39.2%+4.1%

Cumulative growth

Daily Returns

Daily percentage return beside URA.

Daily Out/Under-Performance

Portfolio return minus URA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × URA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded URA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling